August « 2010 « ACTC.OB investor blog

These are the posts from August 2010

August 11, 2010
Posted by admin

Big Pharma losing sleep over stem cell approval?

Anyone reading this is no doubt aware of the fact that Geron (Nasdaq: GERN) just received FDA approval for the first human embryonic stem cell (hESC)-based human clinical trial, targeting spinal cord injuries.
This approval is great news for the industry, and is clearly a watershed moment for the regenerative medicine sector and embryonic stem cell [...]

20 Comments

Posted Under Biotechnology human trials

August 2, 2010
Posted by admin

Getting Closer: FDA’s approval of an hESC Phase I is Great News for Industry!

With Geron’s nod from the FDA to start the human clinical trial of an embryonic stem cell (ESC)-based therapy, and, once FDA approval is secured, ACT anticipates initiation of its Phase I/II ESC-based trial.
Writing for MIT’s Technology Review, Emily Singer states:
“FDA Lets Human Embryonic Stem Cells Trials Resume
Geron will begin tests of its therapy for [...]

2 Comments

Posted Under human trials

ACT's Company Blog.

Advanced Cell Technology, Inc. (OTCBB: ACTC) is a biotechnology company applying cellular technology in the field of regenerative medicine. For more information, visit www.advancedcell.com.

These are the posts from August 2010

Big Pharma losing sleep over stem cell approval?

Getting Closer: FDA’s approval of an hESC Phase I is Great News for Industry!

ACTC.OB Stock Quote

Categories

Archives

Facebook

ACT Links